Ensayo clínico comparativo de eficacia y seguridad de cuatro pautas de tratamiento antirretroviral de alta eficacia (TARGA) en pacientes naive con infección por VIH avanzada

1997, Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial, Lancet, 349, 1413, 10.1016/S0140-6736(97)04441-3 Kline, 1996, Combination therapy with stavudine and didanosine in children with advanced human immunodeficiency virus infection: pharmacokinetic properties, safety, and immunologic and virologic effects, Pediatrics, 97, 886, 10.1542/peds.97.6.886 Table for Grading of Adult Adverse Experiences. Washingon DC: National Institute of Allergy and Infectious Diseases, Division of AIDS; 1992. Mas, 1997, Cuantificación de la viremia por VIH, Med Clin (Barc), 109, 19 Eron, 1995, Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter, N Engl J Med, 333, 1662, 10.1056/NEJM199512213332502 Raboud, 1997, Issues in the design of trials of therapies for subjects with human immunodeficiency virus infection that use plasma RNA level as an outcome, J infect Dis, 175, 576, 10.1093/infdis/175.3.576 Dawson, 1994, Comparing treatment groups on the basis of slopes, areasunder- the-curve, and other summary measures, Drug Inf J, 28, 723, 10.1177/009286159402800308 Byar, 1985, Factorial designs for randomized clinical trials, Cancer Treat Rep, 69, 1055 Armitage, 1987 García, 1999, A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study, AIDS, 13I 17, 2377, 10.1097/00002030-199912030-00009 Albrecht, 2000, Effect of lamivudine in HIV-infected persons with prior exposure to zidovudine/didanosine or zidovudine/zalcitabine. ACTG 303 Study Team, AIDS Res Hum Retroviruses, 16, 1337, 10.1089/08892220050140883 Amador, 2001, Factores de riesgo asociados a la aparición de infecciones durante el primer año de tratamiento antirretroviral de alta eficacia, Med Clin (Barc), 116, 41, 10.1016/S0025-7753(01)71715-0 Maggiolo F, Bottura P, Caprioli S, Migliorino G, Marchetti G, Suter F. HIV-RNA serum levels correlate with CD4 T-Cell Counts [resumen I-246]. Abstract from 8th annual interscience conference on Antimicrobial Agents and Chemotherapy. San Diego, California; 1998. Gulick, 1997, Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy, NEJM, 337, 734, 10.1056/NEJM199709113371102 Gulick, 1998, Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up, JAMA, 280, 35, 10.1001/jama.280.1.35 Hirsch, 1999, A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy, J Infect Dis, 180, 659, 10.1086/314948 Solomon, 1995, Factors associated with initiation of zidovudine in a cohort of injection drug users, J Drug Issues, 25, 225, 10.1177/002204269502500115 Mehta, 1997, Potential factors affecting adherence with HIV therapy, AIDS, 11, 1665, 10.1097/00002030-199714000-00002 Muga, 1999, Mortalidad en una cohorte de usuarios de drogas por vía intravenosa antes de la introducción de la terapia VIH potente, Med Clin (Barc), 112, 721 Demeter, 2001, Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320, Ann Intern Med, 135, 954, 10.7326/0003-4819-135-11-200112040-00007 Cameron, 1998, Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group, Lancet, 351, 543, 10.1016/S0140-6736(97)04161-5 Flexner, 1998, HIV protease inhibitors, N Engl J Med, 338, 1281, 10.1056/NEJM199804303381808 Brau, 1997, Severe hepatitis in three AIDS patients treated with indinavir, Lancet, 349, 924, 10.1016/S0140-6736(05)62700-6 Matsuda, 1997, Severe hepatitis in patients with AIDS and haemophilia B treated with indinavir, Lancet, 350, 364, 10.1016/S0140-6736(05)63416-2 Sulkowski, 2000, Hepatotoxicity associated with antiretroviral therapy in adults infected with HIV and the role of hepatitis C o B virus infection, JAMA, 283, 74, 10.1001/jama.283.1.74 Arribas, 1998, Acute hepatitis in HIV-infected patients during ritonavir treatment, AIDS, 12, 1722 Lana, 2001, Frecuencia y factores predictivos de hepatotoxicidad en pacientes que reciben terapia antirretroviral, Med Clin (Barc), 117, 607, 10.1016/S0025-7753(01)72194-X